Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of concept
CagriSema is the fixed combination of cagrilintide 2.4 mg plus semaglutide 2.4 mg administered as co-injected weekly dosesnot yet a single fixed-dose pen
Still have an emergency one in my drawer
Animal models of Achilles tendon injury show BPC-157 treatment significantly improves recovery as evidenced by biochemical markers and microscopic observations
Hirsch MM, Deckmann I, Fontes-Dutra M, Bauer-Negrini G, Della-Flora Nunes G, Nunes W, Rabelo B, Riesgo R, Margis R, Bambini-Junior V, Gottfried C
A more honest reading shows promising signals in some areas and significant gaps in knee-specific outcomes
US$ 26.31
US$ 22.58
US$ 25.29
US$ 24.18
US$ 25.58
US$ 24.40
US$ 28.66
US$ 22.94
US$ 22.82
